Tower Research Capital LLC (Trc) Vyne Therapeutics Inc. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.12 - $4.91 $176 - $7,222	-1,471 Reduced 5.39%	25,811 $4,000
Q3 2022 Nov 10, 2022	BUY	$0.24 - $4.27 $3,672 - $65,330	15,300 Added 127.69%	27,282 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.37 - $0.71 $1,610 - $3,090	4,353 Added 57.06%	11,982 $5,000
Q1 2022 May 12, 2022	SELL	$0.5 - $1.15 $348 - $801	-697 Reduced 8.37%	7,629 $5,000
Q4 2021 Feb 14, 2022	BUY	$0.91 - $1.5 $2,614 - $4,309	2,873 Added 52.69%	8,326 $8,000
Q3 2021 Nov 15, 2021	BUY	$1.39 - $3.47 $2,160 - $5,392	1,554 Added 39.86%	5,453 $7,000
Q2 2021 Aug 16, 2021	SELL	$3.24 - $6.92 $1,056 - $2,255	-326 Reduced 7.72%	3,899 $14,000
Q1 2021 May 17, 2021	BUY	$6.34 - $12.68 $26,786 - $53,573	4,225 New	4,225 $29,000

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $176M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.